{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:39:09Z","timestamp":1740109149135,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-022-06444-0","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T18:02:46Z","timestamp":1646157766000},"page":"857-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of cytopathologic findings in patients with negative Pap test and positive high-risk HPV infection among three groups"],"prefix":"10.1007","volume":"306","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1198-6886","authenticated-orcid":false,"given":"Sara","family":"Kasraei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7090-8426","authenticated-orcid":false,"given":"Akram","family":"Ghahghaei-nezamabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4356-1038","authenticated-orcid":false,"given":"Akram","family":"Seifollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9019-3904","authenticated-orcid":false,"given":"Faezeh","family":"Aghajani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1113-9257","authenticated-orcid":false,"given":"Amin","family":"Nakhostin-Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3594-711X","authenticated-orcid":false,"given":"Neda","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9119-9593","authenticated-orcid":false,"given":"Afsaneh","family":"Tehranian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"6444_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pvr.2019.04.005","volume":"7","author":"J Doorbar","year":"2019","unstructured":"Doorbar J, Griffin H (2019) Refining our understanding of cervical neoplasia and its cellular origins. Papillomavirus Res 7:176\u2013179","journal-title":"Papillomavirus Res"},{"key":"6444_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","volume":"31","author":"M Schiffman","year":"2003","unstructured":"Schiffman M, Kjaer SK (2003) Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31:14\u201319","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"3","key":"6444_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/jnci\/djs491","volume":"105","author":"A Jemal","year":"2013","unstructured":"Jemal A et al (2013) Annual report to the Nation on the Status of Cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 105(3):175\u2013201","journal-title":"J Natl Cancer Inst"},{"issue":"7364","key":"6444_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/bmj.325.7364.572","volume":"325","author":"SK Kjaer","year":"2002","unstructured":"Kjaer SK et al (2002) Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325(7364):572","journal-title":"BMJ"},{"issue":"9590","key":"6444_CR5","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M et al (2007) Human papillomavirus and cervical cancer. Lancet 370(9590):890\u2013907","journal-title":"Lancet"},{"issue":"3","key":"6444_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00404-021-05986-z","volume":"304","author":"FA Stuebs","year":"2021","unstructured":"Stuebs FA et al (2021) Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix. Arch Gynecol Obstet 304(3):751\u2013758","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"6444_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/jnci\/djs491","volume":"105","author":"A Jemal","year":"2013","unstructured":"Jemal A et al (2013) Annual report to the nation on the status of cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus (HPV)\u2013associated cancers and HPV vaccination coverage levels. JNCI J Natl Cancer Inst 105(3):175\u2013201","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"5","key":"6444_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/ijc.27711","volume":"132","author":"F Bray","year":"2013","unstructured":"Bray F et al (2013) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132(5):1133\u20131145","journal-title":"Int J Cancer"},{"issue":"4","key":"6444_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/LGT.0b013e3182818e31","volume":"17","author":"BK Erickson","year":"2013","unstructured":"Erickson BK, Zhang B, Straughn JM Jr (2013) Screening behaviors and cultural barriers in women with newly diagnosed cervical cancer. J Low Genit Tract Dis 17(4):425\u2013429","journal-title":"J Low Genit Tract Dis"},{"key":"6444_CR10","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","volume":"30","author":"M Arbyn","year":"2012","unstructured":"Arbyn M et al (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30:F88\u2013F99","journal-title":"Vaccine"},{"issue":"7","key":"6444_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jnci\/djn065","volume":"100","author":"G Ronco","year":"2008","unstructured":"Ronco G et al (2008) Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 100(7):492\u2013501","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"6444_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","volume":"136","author":"TC Wright Jr","year":"2011","unstructured":"Wright TC Jr et al (2011) Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. Am J Clin Pathol 136(4):578\u2013586","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"6444_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB et al (2020) 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 24(2):102","journal-title":"J Low Genit Tract Dis"},{"issue":"11","key":"6444_CR14","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1158\/1055-9965.EPI-05-0240","volume":"14","author":"H-T Tsai","year":"2005","unstructured":"Tsai H-T et al (2005) Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk. Cancer Epidemiol Prev Biomark 14(11):2544\u20132549","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"1","key":"6444_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00404-021-06208-2","volume":"305","author":"SM Peace","year":"2022","unstructured":"Peace SM, Jennings AJ (2022) Prevalence of high-grade dysplasia in cytology-negative, HPV-positive cervical cancer screening. Arch Gynecol Obstet 305(1):87\u201393","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"6444_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/dc.23905","volume":"46","author":"\u0130 Karaca","year":"2018","unstructured":"Karaca \u0130 et al (2018) Immediate biopsy of cervical cytology-negative and non-HPV-16\/18 oncogenic types positive patients. Diagn Cytopathol 46(4):326\u2013330","journal-title":"Diagn Cytopathol"},{"issue":"9","key":"6444_CR17","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","volume":"12","author":"PE Castle","year":"2011","unstructured":"Castle PE et al (2011) Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 12(9):880\u2013890","journal-title":"Lancet Oncol"},{"issue":"2","key":"6444_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/jog.14597","volume":"47","author":"S Ayd\u0131n","year":"2021","unstructured":"Ayd\u0131n S et al (2021) Diagnostic performance of immediate colposcopy among women with high-risk human papillomavirus (HPV) other than HPV 16\/18 and normal cytology. J Obstet Gynaecol Res 47(2):720\u2013725","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"6444_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncy.21521","volume":"123","author":"R Nayar","year":"2015","unstructured":"Nayar R, Wilbur DC (2015) The Pap test and Bethesda 2014. Cancer Cytopathol 123(5):271\u2013281","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"6444_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.31557\/APJCP.2019.20.2.417","volume":"20","author":"H Aydo\u011fmu\u015f","year":"2019","unstructured":"Aydo\u011fmu\u015f H, Aydo\u011fmu\u015f S (2019) Comparison of colposcopic biopsy results of patients who have cytomorphological normal but HPV 16\u201318 or other high-risk HPV subtypes positive. Asian Pac J Cancer Prev 20(2):417\u2013420","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"6444_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.28982\/josam.855308","volume":"5","author":"K Koyuncu","year":"2021","unstructured":"Koyuncu K et al (2021) Comparison of biopsy results of HPV 16\/18 and non-16\/18 HPV positive patients with a normal PAP test, a tertiary center experience. J Surg Med 5(1):41\u201345","journal-title":"J Surg Med"},{"issue":"2","key":"6444_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5603\/GP.a2018.0011","volume":"89","author":"F Beyazit","year":"2018","unstructured":"Beyazit F et al (2018) The prevalence of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology. Ginekol Pol 89(2):62\u201367","journal-title":"Ginekol Pol"},{"issue":"3","key":"6444_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1051\/bmdcn\/2018080318","volume":"8","author":"Z Momenimovahed","year":"2018","unstructured":"Momenimovahed Z, Salehiniya H (2018) Cervical cancer in Iran: integrative insights of epidemiological analysis. Biomedicine (Taipei) 8(3):18","journal-title":"Biomedicine (Taipei)"},{"issue":"1","key":"6444_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijgo.12170","volume":"138","author":"G Bogani","year":"2017","unstructured":"Bogani G et al (2017) Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology. Int J Gynaecol Obstet 138(1):62\u201368","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"6444_CR25","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/ijc.30609","volume":"140","author":"S Mittal","year":"2017","unstructured":"Mittal S et al (2017) Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN 1 at baseline\u2014a population-based cohort study. Int J Cancer 140(8):1850\u20131859","journal-title":"Int J Cancer"},{"issue":"1","key":"6444_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.7314\/APJCP.2016.17.1.239","volume":"17","author":"N Khodakarami","year":"2016","unstructured":"Khodakarami N et al (2016) Cervical cancer screening: recommendations for Muslim societies. Asian Pac J Cancer Prev 17(1):239\u2013247","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06444-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T12:36:39Z","timestamp":1661430999000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06444-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["6444"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06444-0","relation":{},"ISSN":["1432-0711"],"issn-type":[{"type":"electronic","value":"1432-0711"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol of the present study was approved by the Tehran University of Medical Sciences Ethics Committee and Iran National Committee for Ethics in Biomedical Research (IR.TUMS.MEDICINE.REC.1398.100).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"We obtained informed consent from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}